Analyst Harshita Polishetty works at BARCLAYS and is covering the the Healthcare sector with 12 price targets and ratings documented since 2018 spanning on 3 stocks. Previously, Harshita Polishetty worked at B. RILEY.
Harshita Polishetty's average stock forecast success ratio is 66.67% with an average time for price targets to be met of 93.67 days.
Most recent stock forecast was given on MRTX, Mirati Therapeutics, Inc at 11-Sep-2019.
Analyst best performing recommendations are on MRTX (MIRATI THERAPEUTICS, INC).
The best stock recommendation documented was for MRTX (MIRATI THERAPEUTICS, INC) at 12/3/2018. The price target of $60 was fulfilled within 38 days with a profit of $19.36 (47.64%) receiving and performance score of 12.54.
Average potential price target upside
Currently, out of the existing stock ratings of Harshita Polishetty - 2 which are a Buy (50%), 2 which are a Hold (50%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
15
18
7 months ago
2/4 (50%)
$6.03 (71.57%)
80
Buy
15
12
7 months 8 days ago
2/2 (100%)
$3.82 (81.50%)
149
Buy
18
7 months 15 days ago
2/3 (66.67%)
$3.28 (38.86%)
99
Buy
26
$11 (73.33%)
3 years 7 days ago
1/10 (10%)
$22.99 (176.49%)
4
Buy
24
$9 (60.00%)
20
3 years 7 days ago
0/5 (0%)
$17.97 (142.19%)
